Post-COVID-19 Cholestasis: A Case Series and Review of Literature.

ABSTRACT:

Background

Coronavirus disease-2019 (COVID-19) cholangiopathy is a recently known entity. There are very few reports of liver transplantation (LT) for COVID-19-induced cholangiopathy. It is well known that vaccines can prevent severe disease and improve outcomes. However, there are no reports on the impact of COVID-19 vaccines on cholestasis. Therefore, we aimed to compare the course and outcome of patients who developed cholestasis following COVID-19 infection among vaccinated and unvaccinated individuals. Methods: Patients diagnosed with post-COVID cholestasis during the pandemic were included in the study after excluding other causes of cholestasis.

Results

Eight unvaccinated and seven vaccinated individuals developed cholestasis following COVID-19 infection. Basel

SUBMITTER: Kulkarni AV 

PROVIDER: S-EPMC9187855 | biostudies-literature | 2022 Nov-Dec

REPOSITORIES: biostudies-literature